AIG
YMAB

American International Group’s Y-mAbs Therapeutics YMAB Stock Holding History

American International Group’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,132
Closed -$295K – 2788
2024
Q1 		$295K Sell
18,132
-155
-0.8% -$2.09K ﹤0.01% 1926
2023
Q4 		$125K Sell
18,287
-74
-0.4% -$428 ﹤0.01% 2435
2023
Q3 		$100K Buy
18,361
+653
+4% +$3.8K ﹤0.01% 2512
2023
Q2 		$120K Sell
17,708
-12
-0.1% -$90 ﹤0.01% 2462
2023
Q1 		$88.8K Buy
17,720
+354
+2% +$1.45K ﹤0.01% 2515
2022
Q4 		$84.7K Sell
17,366
-64
-0.4% -$465 ﹤0.01% 2583
2022
Q3 		$251K Buy
17,430
+246
+1% +$4.07K ﹤0.01% 2031
2022
Q2 		$260K Sell
17,184
-166
-1% -$1.94K ﹤0.01% 2016
2022
Q1 		$206K Sell
17,350
-1,222
-7% -$12.5K ﹤0.01% 2218
2021
Q4 		$301K Sell
18,572
-556
-3% -$11.9K ﹤0.01% 2118
2021
Q3 		$546K Sell
19,128
-454
-2% -$14.3K ﹤0.01% 1793
2021
Q2 		$662 Buy
19,582
+1,799
+10% +$57.7K ﹤0.01% 1759
2021
Q1 		$538 Buy
17,783
+47
+0.3% +$1.93K ﹤0.01% 1795
2020
Q4 		$878 Sell
17,736
-169
-0.9% -$7.82K ﹤0.01% 1458
2020
Q3 		$687K Sell
17,905
-406
-2% -$16.2K ﹤0.01% 1433
2020
Q2 		$791K Buy
18,311
+4,316
+31% +$163K ﹤0.01% 1347
2020
Q1 		$365K Sell
13,995
-810
-5% -$23.5K ﹤0.01% 1579
2019
Q4 		$463K Buy
14,805
+1,955
+15% +$57.8K ﹤0.01% 1730
2019
Q3 		$335K Sell
12,850
-89
-0.7% -$2.27K ﹤0.01% 1873
2019
Q2 		$296K Buy
12,939
+8,498
+191% +$195K ﹤0.01% 2001
2019
Q1 		$116K Sell
4,441
-144
-3% -$3.16K ﹤0.01% 2543
2018
Q4 		$93K Buy
+4,585
New +$105K ﹤0.01% 2635

Other funds holding YMAB

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

American International Group's YMAB Position: Q2 2024 in Review

American International Group sold out of Y-mAbs Therapeutics (YMAB) in Q2 2024, closing a stake of 18,132 shares — an estimated $295K sold.

American International Group first reported a position in YMAB in Q4 2018 and held it in 22 quarters. The position peaked at $791K in Q2 2020. 96 funds tracked by Wall St. Rank hold YMAB as of Q2 2024.

  • American International Group reported no remaining Y-mAbs Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 18,132 Y-mAbs Therapeutics shares in Q2 2024, an estimated $295K.
  • American International Group first reported a position in Y-mAbs Therapeutics in Q4 2018 and held it in 22 quarters.
  • American International Group's Y-mAbs Therapeutics position peaked at $791K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.